Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group
Authors' conclusion
Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.
Study context
- Population
- OMERACT 2023 participants discussing medication adherence trials in rheumatic conditions
- Outcome
- Implementation strategies for the OMERACT-Adherence COS
Methodological detailsOMERACT implementation study, Delphi survey, Consolidated Framework for Implementation Research 2, Preliminary Delphi survey findings discussed at OMERACT 2023 using the Consolidated Framework for Implementation Research 2
- OMERACT implementation study
- Delphi survey
- Consolidated Framework for Implementation Research 2
- Preliminary Delphi survey findings discussed at OMERACT 2023 using the Consolidated Framework for Implementation Research 2
Recommendations
As reported in the abstract
- Simplifying the Core Outcome Set (COS) definitions
- Making it adaptable for clinical practice and drug trials
- Adherence trial training workshops
- Collaborating with key stakeholders such as payers and other COS developers
Original publication
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group. Semin Arthritis Rheum. Published 13 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →